{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T23:32:36Z","timestamp":1779233556337,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.leukres.2009.03.009","type":"journal-article","created":{"date-parts":[[2009,4,30]],"date-time":"2009-04-30T11:34:10Z","timestamp":1241091250000},"page":"1570-1573","source":"Crossref","is-referenced-by-count":19,"title":["Comparative analysis of IL6 promoter and receptor polymorphisms in myelodysplasia and multiple myeloma"],"prefix":"10.1016","volume":"33","author":[{"given":"I.","family":"Aladzsity","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1.","family":"Semsei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Falus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1.","family":"Szil\u00e1gyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Kar\u00e1di","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Varga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"F\u00fcst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"V\u00e1rkonyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2009.03.009_bib1","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1515\/CCLM.2005.160","article-title":"Systemic levels of interleukin-6 and matrix metalloproteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone disease","volume":"43","author":"Sfiridaki","year":"2005","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.leukres.2009.03.009_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1155\/MI.2005.171","article-title":"Serum proinflammatory mediators at different periods of therapy in patients with multiple myeloma","volume":"2005","author":"Kuku","year":"2005","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.leukres.2009.03.009_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-2257.2003.00492.x","article-title":"The clinical and prognostic significance of erythrocyte sedimentation rate (ESR), serum interleukin-6 (IL-6) and acute phase protein levels in multiple myeloma","volume":"25","author":"Alexandrakis","year":"2003","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.leukres.2009.03.009_bib4","first-page":"S23","article-title":"Circulating interleukin-6 (IL-6) in patients with myelodysplastic syndromes","volume":"23","author":"Sefer","year":"1999","journal-title":"Leukemia Res"},{"key":"10.1016\/j.leukres.2009.03.009_bib5","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/cncr.21234","article-title":"Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome","volume":"104","author":"Meyers","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2009.03.009_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev.med.51.1.245","article-title":"Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty","volume":"51","author":"Ershler","year":"2000","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.leukres.2009.03.009_bib7","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1158\/1055-9965.EPI-06-0446","article-title":"Interleukin-6-related genotypes, body mass index, and risk of multiple myeloma and plasmacytoma","volume":"15","author":"Cozen","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.leukres.2009.03.009_bib8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-2141.2001.02497-2a.x","article-title":"Interleukin 6, tumour necrosis factor alpha and lymphotoxin alpha polymorphisms in monoclonal gammopathy of uncertain significance and multiple myeloma","volume":"112","author":"Dring","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2009.03.009_bib9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.imlet.2004.08.015","article-title":"IL-6 and IL-10 promoter gene polymorphisms do not associate with the susceptibility for multiple myeloma","volume":"96","author":"Mazur","year":"2005","journal-title":"Immunol Lett"},{"key":"10.1016\/j.leukres.2009.03.009_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1365-2141.2000.01963.x","article-title":"Interleukin 6, tumour necrosis factor alpha, interleukin 1beta and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma","volume":"109","author":"Zheng","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2009.03.009_bib11","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.leukres.2009.03.009_bib12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1590\/S0100-879X2007000200014","article-title":"Analysis of polymorphism at site \u2212174 G\/C of interleukin-6 promoter region in multiple myeloma","volume":"40","author":"Duch","year":"2007","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.leukres.2009.03.009_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1189\/jlb.1105674","article-title":"Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer","volume":"80","author":"Rose-John","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.leukres.2009.03.009_bib14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/sj.gene.6364120","article-title":"Polymorphisms in the IL-6 receptor (IL-6R) gene: strong evidence that serum levels of soluble IL-6R are genetically influenced","volume":"5","author":"Galicia","year":"2004","journal-title":"Genes Immun"},{"key":"10.1016\/j.leukres.2009.03.009_bib15","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/sj.gene.6364414","article-title":"A common variant of the interleukin 6 receptor (IL-6r) gene increases IL-6r and IL-6 levels, without other inflammatory effects","volume":"8","author":"Rafiq","year":"2007","journal-title":"Genes Immun"},{"key":"10.1016\/j.leukres.2009.03.009_bib16","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI2629","article-title":"The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis","volume":"102","author":"Fishman","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.leukres.2009.03.009_bib17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0531-5565(01)00197-8","article-title":"The \u2212174C\/G locus affects in vitro\/in vivo IL-6 production during aging","volume":"37","author":"Olivieri","year":"2002","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.leukres.2009.03.009_bib18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-2249.2006.03273.x","article-title":"The impact of interleukin-6 promoter \u2212597\/\u2212572\/\u2212174genotype on interleukin-6 production after lipopolysaccharide stimulation","volume":"147","author":"Muller-Steinhardt","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.leukres.2009.03.009_bib19","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1182\/blood-2002-10-3235","article-title":"Hepcidin a putative mediator of anemia of inflammation, is a type II acute-phase protein","volume":"101","author":"Nemeth","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.03.009_bib20","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00277-006-0178-1","article-title":"The significance of the hemochromatosis genetic variants in multiple myeloma in comparison to that of myelodysplastic syndrome","volume":"85","author":"Varkonyi","year":"2006","journal-title":"Ann Hematol"},{"key":"10.1016\/j.leukres.2009.03.009_bib21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/ncpgasthep0019","article-title":"Mechanisms of disease: the role of hepcidin in iron homeostasis\u2014implications for hemochromatosis and other disorders","volume":"1","author":"Pietrangelo","year":"2004","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.leukres.2009.03.009_bib22","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1053\/j.gastro.2006.10.018","article-title":"STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo","volume":"132","author":"Pietrangelo","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.leukres.2009.03.009_bib23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000068487","article-title":"High incidence of hemochromatosis gene mutations in the myelodysplastic syndrome: the Budapest Study on 50 patients","volume":"109","author":"Varkonyi","year":"2003","journal-title":"Acta Haematol"},{"key":"10.1016\/j.leukres.2009.03.009_bib24","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/ajh.20995","article-title":"Hemochromatosis-associated gene mutations in patients with myelodysplastic syndromes with refractory anemia with ringed sideroblasts","volume":"82","author":"Nearman","year":"2007","journal-title":"Am J Hematol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609001179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609001179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T23:44:27Z","timestamp":1684971867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212609001179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0145212609001179"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2009.03.009","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}